RGNT · Regentis Biomaterials Ltd.
Market Cap
$13.28M
Shares
7.02M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.89
Open$2.02
Day$1.89–2.02
Available close range$1.28–9.40
Avg vol 30d50K
Short int13K · 0.2% float · 1.0d
Short vol32%
DataDec 2025–Sep 2026
The closing range uses available history since Dec 4, 2025; less than a full year is stored.
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-79.5%
Year over year · fewer shares
Price change (1Y)
—
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−16%
below
RSI (14)
41
neutral
MACD trend
Positive
52-week position
8%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−40%
trailing
YTD return
−72%
this year
Relative strength
−58%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+100% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.19% of float · ▲ +64.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Squeeze score
37
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
632%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
9.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−16%
Bearish
RSI (14)
41
Neutral
MACD trend
Positive
Bullish
52-week position
8%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+100% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.19% of float · ▲ +64.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Price context
position in its available closing range
Range low $1
Now $2 · 8%
Range high $9
vs 50-day avg -16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RGNT
this stock
Regentis Biomaterials Ltd.
|
$13.28M | -72.0% | — | — | 0.2% |
|
ISRG
Intuitive Surgical Inc
|
$130.41B | -34.8% | +20.5% | 42.4 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$48.31B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$42.77B | -22.5% | +11.5% | — | 3.0% |
|
ALC
Alcon Inc
|
$31.95B | -16.2% | +10.5% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
6
- % held
- 12.0%
- Net QoQ
- +293.9K sh
- Top holder
- Rosalind Advisors, Inc.
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RGNT | -4.1% | -0.5% | -40.1% | -7.4% | -72.0% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -2.9% | +1.2% | -57.9% | -7.0% | -84.0% |